The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2013
Filed:
Nov. 27, 2009
Takahiro Kitamura, Fuji, JP;
Hajime Yamada, Higashimurayama, JP;
Shunji Takemura, Higashimurayama, JP;
Masanori Ashikawa, Higashimurayama, JP;
Tetsuya Ishikawa, Tokyo, JP;
Yoshiharu Miyake, Higashimurayama, JP;
Akiyasu Kouketsu, Higashimurayama, JP;
Seiichi Sato, Higashimurayama, JP;
Hiroyuki Ishiwata, Higashimurayama, JP;
Yuichiro Tabunoki, Higashimurayama, JP;
Manabu Shibasaki, Higashimurayama, JP;
Takatoshi Ozawa, Tokyo, JP;
Ryota Shigemi, Higashimurayama, JP;
Takeshi Doi, Higashimurayama, JP;
Masahiro Tamura, Higashimurayama, JP;
Takahiro Kitamura, Fuji, JP;
Hajime Yamada, Higashimurayama, JP;
Shunji Takemura, Higashimurayama, JP;
Masanori Ashikawa, Higashimurayama, JP;
Tetsuya Ishikawa, Tokyo, JP;
Yoshiharu Miyake, Higashimurayama, JP;
Akiyasu Kouketsu, Higashimurayama, JP;
Seiichi Sato, Higashimurayama, JP;
Hiroyuki Ishiwata, Higashimurayama, JP;
Yuichiro Tabunoki, Higashimurayama, JP;
Manabu Shibasaki, Higashimurayama, JP;
Takatoshi Ozawa, Tokyo, JP;
Ryota Shigemi, Higashimurayama, JP;
Takeshi Doi, Higashimurayama, JP;
Masahiro Tamura, Higashimurayama, JP;
Kowa Company, Ltd., Aichi, JP;
Abstract
To provide a novel JAK3 inhibitor that is useful as a preventive and/or therapeutic agent for rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjögren syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic rhinitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia and the like. The pyridine-3-carboxyamide derivative represented by the general formula (1): or its salt or a solvate thereof.